pyrazines has been researched along with Cadaver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bortolotto, A; Camargo, J; Camargo, S; Canabarro, R; Costa, C; Felicetti, J; Fernandes, S; Machuca, T; Michelon, T; Neumann, J; Perin, F; Sanchez, L; Schio, S; Sporleder, H; Tarrasconi, H | 1 |
| Alberú, J; Leyva, S; Marino-Vázquez, LA; Morales-Buenrostro, LE; Reyes-Loaeza, JA; Uribe-Uribe, N; Vega, O | 1 |
| Dagher, NN; Lonze, BE; Montgomery, RA; Segev, DL; Simpkins, CE; Singer, AL; Zachary, AA | 1 |
3 other study(ies) available for pyrazines and Cadaver
| Article | Year |
|---|---|
Acute humoral rejection in a lung recipient: reversion with bortezomib.
Topics: Adult; Biopsy; Boronic Acids; Bortezomib; Cadaver; Female; Graft Rejection; Humans; Immunity, Humoral; Lung Transplantation; Middle Aged; Postoperative Complications; Protease Inhibitors; Pyrazines; T-Lymphocytes; Tissue Donors; Treatment Outcome | 2010 |
Bortezomib for antibody mediated rejection treatment: experience at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City.
Topics: Adult; Autoantibodies; Biopsy; Boronic Acids; Bortezomib; Cadaver; Creatinine; Female; Graft Rejection; HLA Antigens; Humans; Living Donors; Male; Mexico; Protease Inhibitors; Pyrazines; T-Lymphocytes; Tissue Donors; Treatment Outcome | 2009 |
The fate of anti-HLA antibody among renal transplantation recipients treated with bortezomib.
Topics: Adult; Autoantibodies; Boronic Acids; Bortezomib; Cadaver; Creatinine; Female; Histocompatibility Antigens Class I; HLA Antigens; HLA-D Antigens; HLA-DQ Antigens; Humans; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Male; Middle Aged; Protease Inhibitors; Pyrazines; Tissue Donors | 2009 |